Lancet Diabetes & Endocrinology

Papers
(The H4-Index of Lancet Diabetes & Endocrinology is 66. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Long-term trial outcomes of Roux-en-Y gastric bypass and one anastomosis gastric bypass: tipping the scale1003
World Health Assembly ratifies first global diabetes targets695
Mark Atkinson: bringing two worlds together607
What's preventing us from curbing the obesity crisis?593
Direct-to-consumer services: improving access to care for people with diabetes and obesity440
Better testing and labelling of drugs for people with obesity436
Correction to Lancet Diabetes Endocrinol 2022; 10: 489–98432
Type 1 diabetes screening: need for ethical, equity, and health systems perspective420
Artificial intelligence and diabetes: time for action and caution397
Metastases to the thyroid gland: how does this affect cytohistological diagnoses?361
South Africa to produce insulin for Africa in 2024360
Anand Hardikar: a scientific nomad searching for the truth331
Correction to Lancet Diabetes Endocrinol 2022; published online Sept 29. https://doi.org/10.1016/S2213-8587(22)00252-2286
Reassessing driving safety in diabetes275
International Federation for the Surgery of Obesity statement on metabolic bariatric surgery after pharmacotherapy-induced weight loss in clinical obesity264
Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial218
A framework for improving diabetes care in humanitarian emergencies218
Implications of technology guidelines for low-income and middle-income countries210
Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, p208
Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials195
Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality194
Estimating direct tissue effects versus weight loss effects of incretin-based drugs for obesity on various chronic conditions193
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial179
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice166
Obesity in people living with type 1 diabetes161
Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial154
Nutritional intake and bone health147
Jennifer Manne-Goehler: at the crossroads of pandemics146
The uncomfortable truth about kidney disease in type 1 diabetes138
Explaining the high rate of progression from prediabetes to type 2 diabetes in China137
A roadmap for integrating mental health and diabetes services137
Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials136
Dapagliflozin in patients with COVID-19: truth or dare135
Putting wellbeing at the core of diabetes care134
Association of glycaemic index and glycaemic load with type 2 diabetes in the PURE study127
Glycaemic index as part of the diabetes prevention strategy125
Behind the scenes: epigenetic mechanisms rule the roost in pubertal timing124
Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial – Authors' reply119
The Human Insulin Thermal Solution project—a private sector initiative to address the thermostability of insulin119
Levothyroxine treatment in euthyroid women positive for thyroid peroxidase antibodies and recurrent pregnancy loss118
Lebanon: insulin out of reach after subsidies lifted118
Principles for virtual health care to deliver real equity in diabetes118
What does renal failure teach us about our National Health System?116
Correction to Lancet Diabetes Endocrinol 2025; published online April 7. https://doi.org/10.1016/S2213-8587(25)00087-7110
The role of nurses in diabetes care: challenges and opportunities102
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study102
Rising diabetes diagnosis in long COVID100
Challenging diabetes stigma starts and ends with all of us99
Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial98
Healthy weight for the next generation's health in China98
The changing character of diabetes complications97
The promise and hope of GLP-1 receptor agonists97
Retraction and republication—Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses93
Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history90
Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis88
The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 202087
Childhood obesity: a growing pandemic87
Women in diabetes research: stepping towards equity81
Is it time to re-assess the development of thyroid function reference ranges?80
Blood pressure control according to type 2 diabetes status73
Correction to Lancet Diabetes Endocrinol 2023; 11: 402–1372
Correction to Lancet Diabetes Endocrinol 2022; 10: 407–1771
Homing in on the causes of male infertility68
Aberrant hormone receptors regulate a wide spectrum of endocrine tumors68
Male hypogonadism: pathogenesis, diagnosis, and management67
CONCEPTT to care: the science of implementation in diabetes care66
0.084303140640259